Heim, Payne & Chorush, LLP, recently helped a group of clients win court approval for a settlement requiring multinational pharmaceutical company Pfizer Inc. to pay $93 million for delaying a cheaper generic version of its popular cholesterol medication Lipitor®. Heim, Payne & Chorush partners Russell Chorush, Blaine Larson, and Allan Bullwinkel, and associates Carlos Ruiz,
Read moreHeim, Payne & Chorush and founding partner Michael Heim have been selected for the IP Stars 2024 rankings published by London-based Managing IP. Corporations and in-house counsel have relied on the annual IP Stars guide for three decades when making hiring decisions for intellectual property cases. Mr. Heim and Heim, Payne & Chorush earned selections
Read moreWASHINGTON, D.C. – A team of attorneys from the Houston intellectual property boutique Heim, Payne & Chorush, LLP, recently won three significant legal rulings in two days on behalf of Texas-based Atlas Global Technologies Inc. The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) issued a 42-page decision on April 11 denying
Read moreWASHINGTON, D.C. – Attorneys from the Houston intellectual property litigation boutique Heim, Payne & Chorush LLP have won another key ruling against automobile manufacturing giant BMW of North America, LLC, on behalf of firm client Arigna Technology Limited of Ireland. Firm partner Mike Heim and associate Chris Limbacher defeated BMW’s attempt to invalidate 32 separate
Read moreHeim, Payne & Chorush LLP partner Russell Chorush and co-counsel recently won a key ruling for his clients in a hotly contested antitrust lawsuit against Illinois-based AbbVie and Paris, France-based Besins Healthcare, two of the world’s leading pharmaceutical drug companies. Dr. Chorush represents a group of direct purchasers of pharmaceutical drugs who sued the drug companies for wrongly delaying
Read more
